Alle afleveringen
283 afleveringen, van nieuw naar oud
-
Episode 24 - Laurent Audoly, CEO & Founder Privebio part 2
8 november 2024 · 34 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We have the pleasure of speaking with Laurent Audoly. Laurent is the co-founder and CEO of PriveBio, a precision medicine biotech focused on tackling metabolic dysfunction and fibro-inflammation in cardiorenal metabolic diseases.
Having had roles at Pfizer, Merck, Kymera Therapeutics, and more, Laurent has been instrumental in bringing several novel medicines to market, including 9 through IND and helping 100’s of thousands of patients. He has also successfully led multiple biotech startups.
Join us as we delve into Laurent's journey, the challenges he has faced, and his vision for the future of PriveBio and the biotech industry.
Enjoy and stay tuned.
-
Episode 18 - Ravneesh Sachdev, Partner & Head of Business Development at Apple Tree Partners
7 november 2024 · 23 min
Thank you for tuning into another episode of Bio Hub! Today, we have the privilege of hosting Ravneesh Sachdev, a seasoned leader in the biotech industry and the currently partner and Head of Business Development at Apple Tree Partners. Ravneesh experience is vast, spanning over two decades in leadership roles across the biotech landscape. He has previously served as SVP Head of Business Development at Acceleron, VP Head of Business Development at Sage Therapeutics, VP Business Development at Bioveritav and Executive Director Business Development at Acorda Therapeutics. Lees meer
-
Episode 24 - Laurent Audoly, CEO & Founder Privebio part 1
6 november 2024 · 40 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We have the pleasure of speaking with Laurent Audoly. Laurent is the co-founder and CEO of PriveBio, a precision medicine biotech focused on tackling metabolic dysfunction and fibro-inflammation in cardiorenal metabolic diseases.
Having had roles at Pfizer, Merck, Kymera Therapeutics, and more, Laurent has been instrumental in bringing several novel medicines to market, including 9 through IND and helping 100’s of thousands of patients. He has also successfully led multiple biotech startups.
Join us as we delve into Laurent's journey, the challenges he has faced, and his vision for the future of PriveBio and the biotech industry.
Enjoy and stay tuned.
-
Episode 23 - Douglas Love, CEO Annexon Biosciences
30 oktober 2024 · 33 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We're thrilled to welcome Doug Love, the dynamic President and Chief Executive Officer of Annexon Biosciences. With a storied career that spans over two decades in biotech, Douglas brings a wealth of experience from his transformative roles at companies like Elan Pharmaceuticals and Genentech.
At Annexon, he's at the helm of pioneering treatments for classical complement-mediated disorders, driving forward innovations that promise to change the lives of patients around the globe.
Join us as Douglas shares his journey through the biotech landscape, the challenges and achievements of leading Annexon, and his vision for the future of medical treatments.
Enjoy and stay tuned.
-
Episode 20 - Amit Kumar, Chairman, President and CEO at Anixa Biosciences
24 oktober 2024 · 25 min
Thank you for tuning into another episode of Bio Hub! Today, we have the privilege of hosting Amit Kumar, a seasoned leader in the biotech industry and the current CEO & Chairman of Anixa Biosciences. Amit's experience is vast, spanning over two decades in leadership roles across the biotech landscape. He has previously served as CEO of CombiMatrix, a key player in molecular diagnostics, as well as GFF, and is also the Executive Chairman and co-founder of Actym Therapeutics, a company advancing immune oncology treatments. Lees meer
Now, at the helm of Anixa Biosciences, Amit is focused on addressing some of the most critical unmet needs in oncology. Under his leadership, the company is advancing cutting-edge therapies and vaccines aimed at tackling cancer, including innovative approaches in immunotherapy and vaccine development.
Amit’s deep expertise, from startups to larger biotech companies, gives him a unique perspective on how to steer innovative science towards tangible clinical outcomes. We're excited to dive into his journey, the challenges and successes along the way, and what's next for Anixa and the broader biotech space.
-
Episode 22 - Daniel Couto, COO Vedanta Biosciences
23 oktober 2024 · 38 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
With nearly three decades of experience in biopharmaceutical development and manufacturing, Daniel's career spans both major pharmaceutical companies and innovative biotech firms.
Prior to joining Vedanta, he held senior leadership roles at organizations like ContraFect Corporation, Merck Sharp Dohme Biologics, and Nuvelo Inc., where he contributed to advancing various drug candidates and therapeutic approaches.
At Vedanta, Daniel is leading the charge in developing microbiome-based therapies to address immune-mediated and infectious diseases. His deep expertise in operations management and passion for team building have played a crucial role in shaping Vedanta's distinctive culture and advancing its mission.
In this episode, we’ll explore Daniel’s professional journey, the ground-breaking work at Vedanta, the culture he has helped cultivate, and the opportunities and challenges facing the biotech industry.
-
Episode 21 - Chris Haqq - CMO Elicio Therapeutics
16 oktober 2024 · 34 min
Welcome back to another episode of The BioHub! Lees meer
Today, we’re thrilled to have Dr. Chris Haqq, Chief Medical Officer and Head of Research & Development at Elicio Therapeutics, join us.
Chris is an expert in immuno-oncology with over 20 years of experience in the biotech industry. He has a remarkable track record in leading innovative therapies from concept to clinical stages, including his pivotal role in developing groundbreaking T cell therapies at Atara Biotherapeutics.
In this episode, we’ll explore Elicio’s unique approach to cancer immunotherapy, Chris’s insights on the current biotech landscape, and what it takes to lead in such a challenging field.
-
Episode 19 - Martin Taylor - F-Prime Capital
11 oktober 2024 · 42 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We’re thrilled to have Martin Taylor, Senior Associate at F-Prime Capital. With a strong background in molecular biology and DNA research, Martin transitioned from the lab to venture capital, where he now helps identify and support innovative biotech companies.
In this episode, we’ll explore Martin’s journey, his role at F-Prime, and his insights into the future of biotech.
Enjoy and stay tuned.
-
Episode 16 - Angelo Stracquatanio, CEO & Co-Founder Apprentice.io
26 september 2024 · 54 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We have an extraordinary guest, Angelo Stracquatanio, the Co-founder and CEO of Apprentice.io. Angelo is a visionary in the life sciences industry, leading the world's first cloud-based, manufacturing execution system for life sciences.
With over $200M raised from leading VC funds and being ranked #60 fastest-growing software company on the Inc 5000, Apprentice.io is revolutionizing the industry with its innovative solutions.
Enjoy and stay tuned.
-
Episode 15 - TJ Cradick, Gene Editing Frontiers
18 september 2024 · 32 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We have the honor of hosting TJ Cradick, a pioneering leader in CRISPR technology.
TJ is currently focused on CRISPR consulting and advising new gene-editing companies. He was previously the Chief Scientific Officer at Excision BioTherapeutics, where he led the development of CRISPR-based therapies for viral diseases. Before that, TJ was the 2nd US employee and Head of Genome editing at CRISPR Therapeutics and played a crucial role in the company's growth to a clinical-stage biotech.
Having been in the space since 2000, we’ve got so much to cover. we'll be exploring TJ's journey, the challenges and triumphs of developing CRISPR technology, and the future of genome editing.
Enjoy and stay tuned.
-
Episode 14 - Raphael Ognar, CEO & Co-Founder NKILT Therapeutics
10 september 2024 · 50 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
we have an incredible episode lined up with a phenomenal guest, Raphael Ognar! Raphael is the President & CEO, and Co-Founder of NKILT Therapeutics, a biotech company developing innovative cell therapies to target leukemias and solid tumors. With over 25 years in the pharma and biotech industries, Raphael has a wealth of experience in oncology, hematology, and cell therapy.
We'll explore the origin of NKILT, how Raphael found the right partners, and the challenges of securing funding for early-stage biotechs. He'll also share his journey at companies like Celgene and BMS, how he handles pressure, and his decision-making process as a CEO.
Enjoy and stay tuned.
-
Episode 13 - David Slack, CEO Impilo Therapeutics
5 september 2024 · 28 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
we have the pleasure of hosting David Slack, CEO of Impilo Therapeutics. With over 30 years of experience in the biopharmaceutical industry, David has a proven track record in creating value for companies and investors through strategic partnerships and innovative financing transactions.
David’s impressive career includes leadership roles at public and private biotech firms, as well as major pharmaceutical companies. He played a pivotal role in the merger of Cend Therapeutics with Caladrius Biosciences to form Lisata Therapeutics, and later co-founded Impilo Therapeutics to focus on nucleic acid-based medicine for treating solid tumor cancers.
In this episode, we'll explore David's journey from R&D to business development, the challenges and opportunities in the biotech industry, and the exciting future of Impilo Therapeutics.
Enjoy and stay tuned!
-
Episode 12 - Jerry McLaughlin, CEO Life Biosciences
29 augustus 2024 · 46 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
Today, we have a special guest, Jerry McLaughlin, CEO of Life Biosciences.
With over 30 years in the biopharmaceutical industry, Jerry has been instrumental in the development and commercialization of more than a dozen FDA-approved drugs. His impressive career started at Merck, and went on to leading roles at Endo, Neos Therapeutics, AgeneBio, and NuPathe.
Life Biosciences is dedicated to extending healthy human lifespan by targeting the biological causes of aging.
In this episode, we'll explore Jerry's journey from big pharma to biotech startups, his path to becoming a CEO, and the innovative work at Life Biosciences.
Enjoy and stay Tuned!
-
Episode 11 - Arjun Goyal, Co-Founder of Vida Ventures
23 augustus 2024 · 37 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We're thrilled to have Dr. Arjun Goyal!
Arjun is the Co-Founder and Managing Director of Vida Ventures, a leading life sciences venture capital firm with approximately $2 billion under management.
He serves on the boards of companies like Scorpion Therapeutics and Quanta Therapeutics, and has played key roles in several high-profile investments and acquisitions.
We'll dive into Arjun's journey from physician to investor, the story behind Vida Ventures, and what they look for in executives and new company investments. He'll also share insights into current market trends, his decision-making processes, and what sets his mindset apart.
It's an absolute pleasure to welcome Dr. Arjun Goyal!
Enjoy and stay tuned!
-
Episode 10 - Jason Lettmann, CEO ALX Oncology
9 augustus 2024 · 36 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We’re excited to host Jason Lettmann, the CEO of ALX Oncology. Jason brings a wealth of experience from his roles as General Partner at Lightstone Ventures and CEO of Promedior Inc., where he led the company to a successful acquisition by Roche. With over a decade of leadership in biotech and venture capital, Jason is now steering ALX Oncology towards groundbreaking advancements in immuno-oncology.
Join us as we dive into Jason's journey, the challenges and successes of ALX Oncology, and their innovative approach to cancer treatment. Welcome to the show, Jason!
Enjoy and stay tuned!
-
Episode 09 - Stella Vnook, CEO Likarda
31 juli 2024 · 32 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
Today, we have an exceptional guest joining us, Dr. Stella Vnook! Stella is a seasoned biopharmaceutical executive with over 25 years of experience driving transformational change in the industry. She has a remarkable track record of building and managing successful startups, from early-stage R&D through to commercialization. As the CEO of Likarda Biotech and the founder of multiple companies, including OralBioLife, Dialysis Biosciences, and ACG Group, Stella is a true innovator in the biotech space.
In this episode, we’ll explore Stella’s journey, her insights on building successful biotech startups, and her unique approach to hiring first-time CEOs. We’ll also discuss her experiences with gender dynamics in the industry, managing risks in smaller biotech firms, and the importance of diversity and inclusion.
Stella will share her thoughts on the future of cell therapies and the legacy she hopes to leave in the biotech world. It’s an absolute pleasure to welcome Dr. Stella Vnook!
Enjoy and stay tuned!
-
Episode 08 - Nicole Lambert, Former COO of Myriad Genetics
24 juli 2024 · 30 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
Today, we're super excited to welcome a phenomenal guest, Nicole Lambert!
Nicole is a business leader with over two decades of experience at Myriad Genetics, where she played a pivotal role in advancing genetic testing and precision medicine. Recently, she transitioned from her role as Chief Operating Officer to focus on new professional opportunities and continues her impactful work as a senior advisor and board member of Arcus Biosciences.
I first met Nicole when she messaged me on LinkedIn, exploring board roles, and I had the pleasure of placing her on Arcus Biosciences' board. We're diving into some fascinating topics today! We'll explore Nicole's journey at Myriad, how she stayed motivated, her personal connection to genetic testing, and the challenges and successes she faced in her career.
Nicole will also share her insights on handling burnout, the role of women in biotech, and the future of healthcare.
-
Episode 07 - David Mazzo, CEO of Lisata Therapeutics
17 juli 2024 · 40 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
Today, we’re honored to have Dr. David Mazzo with us!
David is the President and CEO of Lisata Therapeutics, a company dedicated to developing innovative therapies for advanced solid tumors and other major diseases. With a career spanning over 40 years in the pharmaceutical industry, we have so much to discuss.
We'll dive into David's journey, the evolution of Lisata
following the merger with Caladrius Biosciences and Cend Therapeutics, and their lead product candidate. He'll also share insights on making tough decisions, fostering a dynamic company culture, and the future of oncology
treatment.It's an absolute pleasure to welcome Dr. David Mazzo!
Enjoy and stay tuned!
-
Episode 06 - Rob Etherington, CEO of Clene Nanomedicine
10 juli 2024 · 31 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
Joining us today is Rob Etherington, CEO of Clene Nanomedicine.
Rob brings over 30 years of experience in pharma, including 8 years at Parke-Davis, 13 years at Actelion—where he was part of the team that took the company public—and now, 11 years leading Clene.
At Clene, he's at the forefront of using nanotechnology to tackle neurodegenerative diseases.
Enjoy and stay tuned!
-
Episode 05 - Christina Trojel-Hansen, EIR ARCH Venture Partners
4 juli 2024 · 36 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We’re excited to host Dr. Christina Trojel-Hansen. Christina is a leading figure in biotech, having co-founded several innovative companies, including Tune Therapeutics, which specializes in gene regulation technology, Oscine Therapeutics, which is making significant advancements in CNS cell therapy, and Pretzel Therapeutics, focused on mitochondrial diseases.
As an Entrepreneur in Residence at ARCH Venture Partners, Christina has played a pivotal role in transforming early-stage ideas into viable medical breakthroughs.
Christina’s strategic insight has also been instrumental in
securing major Series A investments for biotech innovators like Adcendo and Stipe Therapeutics.Her leadership and vision have earned her a place among the Top 10 Inspirational Women in Nordic Life Science and the Endpoints 20 under 40, highlighting her as a future leader in biotech.
Join us as we delve into her story of entrepreneurship,
innovation, and leadership in the biotech landscape.Enjoy and stay tuned
-
Episode 04 - Michael Parini, CEO of Spur Therapeutics (Freeline)
26 juni 2024 · 38 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We're super excited to welcome a phenomenal guest, Michael Parini!
Michael is the CEO of Spur Therapeutics, a clinical-stage biotechnology company dedicated to developing transformative gene therapies for chronic debilitating diseases. With over 20 years of experience as a senior executive in the biopharma and biotech industries, Michael has held key roles at Vertex and Pfizer before joining Spur.
In this episode, we’ll dive into the exciting rebrand of Freeline now spur, what inspired Michael to join the company, and how Spur is approaching gene therapy in innovative ways. We’ll also discuss the challenges of reshaping the company, maintaining stability and culture, the importance of diversity and inclusion, and how Freeline is making a difference for patients.
Enjoy and stay tuned
-
Episode 03 - Matthew Shaulis, CCO & US President of Hansa Bio
21 juni 2024 · 41 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We're super excited to welcome a phenomenal guest, Matthew Shaulis!
Matthew is the Chief Commercial Officer and US President of Hansa Biopharma. With over 20 years of experience in the pharmaceutical industry, he's held top executive roles at giants like Pfizer and Teva. Now, he's leading the charge at Hansa, bringing groundbreaking treatments for rare immunological diseases to the US.
We're diving into some fascinating topics today! We'll explore the incredible growth of Hansa Biopharma, what makes it stand out, and the unique challenges and opportunities in the biotech world.
Matthew will share his insights on making tough business decisions, navigating the unpredictable biotech landscape, and the exciting milestones ahead for Hansa. Plus, we'll get a peek into his personal journey and what fuels his impressive career.
Enjoy and stay tuned
-
Episode 02 - Someit Sidhu, Founder & Former CEO of Zura Bio
31 mei 2024 · 39 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We were thrilled to welcome Someit Sidhu, an inspiring entrepreneur who has made significant strides in the biotech industry.
Someit is the founder of multiple groundbreaking companies, including Zura Bio, where he successfully led the company through a strategic SPAC merger and a notable public offering.
He also founded Izana Bioscience, which he successfully sold to Roivant Sciences, and his first venture, Pathios Therapeutics.
Enjoy and stay tuned
-
Episode 01 - Tushar Pandey, Co-Founder & CEO of Simbiosys
15 mei 2024 · 27 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
Today we welcome a true visionary with the co-founder and CEO of Simbiosys
Leading the charge of such an innovative company, which is revolutionizing cancer care by blending artificial intelligence with personalized medicine.
I'm thrilled about the insights and stories we're about to uncover as we welcome Tushar Pandey to the show.
Enjoy and stay tuned.
-
Episode 08 - Barbara Ryan, Biotech/Pharma Wall Street Veteran
7 maart 2024 · 51 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We have Barbara Ryan who has over 40 years in Healthcare capital Markets with 31 years on wall street!
She currently serves on 6 biotech boards including Indivior and MINK.
She has raised over $1.5B for emerging biopharma companies in IPOs, follow-ons and convertible debt transactions.
She is also the Founder of Fabulous Pharma Females, a non-profit dedicated to advancing and mentoring women in biopharma.
Enjoy and stay tuned.
-
Episode 07 - Owen Hughes, CEO of XOMA & Partner at Atlas Venture
28 februari 2024 · 39 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
We have Owen Hughes who has spent the last 25 years in healthcare as both an operator and investor.
Currently the CEO of XOMA, former CEO of Sail Bio and former CEO and co-founder of Cullinan Oncology, who did $380M in private raises before a $250M IPO in 2021. Prior to Cullinan he served as CBO for Intarcia Therapeutics.
He started his career on wall street, initially in equity research at Morgan Stanley before transitioning to buyside, where he managed public and private healthcare investments for Brookside Capital.
Hewas also the Chairman of Radius Health before it’s sale of 890 million dollars, Lead independent director for Translate bio before it’s sale of $3.2B and is currently Chairman of Ikena Oncology.
Enjoy and stay tuned.
-
Episode 06 - Frank Watanabe, CEO & President Arcutis Biotherapeutics
21 februari 2024 · 35 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
This week we welcome Frank Watanabe! CEO and President of Arcutis Therapeutics, where he has been since it's founding in 2016.
During that time they have done multiple successful raises, an $160M IPO and have developed more than 2 FDA approved products with a 3rd being reviewed.
Before this he was COO and co-founder of Kanan Therapeutics and VP of strategy and corporate development at Kythera.
He also held numerous exec roles throughout his time at Amgen and Eli Lilly and was involved in the development and marketing of 3 approved drugs.
He was also a commissioned officer in the US Navy reserves for 25 years.
Enjoy and stay tuned.
-
Episode 05 - Dr Paul Peter Tak, CEO & President Candel Therapeutics
14 februari 2024 · 33 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
This week we welcome Paul Peter Tak! CEO and President of Candel Therapeutics
From a professorship in his native Netherlands to the SVP, Chief Immunology Officer, and global development leader at GSK, and from leading small biotechs such as Tempero and Kintai to entering the venture world as a Flagship partner.
Now, he is the CEO and President of Candel Therapeutics – a promising clinical immunotherapy company in the fight against cancer.
Enjoy and stay tuned.
-
Episode 04 - Marc De Garidel, CEO Abivax & Chairman Ipsen
31 januari 2024 · 32 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
40 years of experience across biotech and pharma! 6 years as CEO of Ipsen, where he currently serves as Chairman.
He led the successful sale of Cincor Pharma for 1.8 Billion dollars to Astrazeneca and the sale of Corvidia to Novo Nordisk for 2.1 billion dollars.
Now he serves as the CEO of Abivax, who just completed the largest ever NASDAQ IPO for a French biotech!
Enjoy and stay tuned
-
Episode 03 - Dr Stanley Lewis, CEO & Founder A28 Therapeutics
24 januari 2024 · 40 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
This week we welcome Dr Stanley Lewis the CEO and founder of A28 Therapeutics.
With a remarkable 25-year career in life sciences across clinical research, and drug development, he is a true leader in the field.
Formerly Chief Medical Officer at Ansun Biopharma, he successfully led late-stage trials, helped secure a $100 million Series B, and contributed to strategic in-licensing efforts.
In 2021, he founded A28, aiming to revolutionize global cancer care.Enjoy and stay tuned
-
Episode 02 - Dr Chris Mirabelli, Chairman Leap Therapeutics, co-Founder Ionis
16 januari 2024 · 30 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
This week we welcome Dr. Chris Mirabelli, who has 40 years of experience across Biotech and Pharma. Currently serving as Chairman of Leap Therapeutics, where he was the CEO from its founding in 2015 until 2020.
A managing Director of HealthCare ventures, where since joining in 2000, they have raised 1 billion dollars across 4 funds and has been involved in over 15 investments leading to successful exits.
Before his VC ventures, he was the CEO and Chairman of LeukoSite from its inception in 1993 until its acquisition by Millennium in 1999.
Before that he was a co-founder of Ionis Pharma who today sit at a 7-billion-dollar market cap and a workforce of 1,000 employees.Enjoy and stay tuned
-
Episode 01 - Dr Michael Tusche, Former co-CEO of Treadwell Therapeutics
10 januari 2024 · 29 min
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Lees meer
This week we welcome Dr. Michael Tusche, who has 20 years of experience spanning, science, wall street and biotech. He was employee number one and co-CEO of Treadwell Therapeutics where they raised $118M, advanced 3 assets into the clinic and expanded the team to 50+.
Enjoy and stay tuned.
-
Episode 99 - Lance Baldo - CEO of Beacon Therapeutics
1 januari 1970 · 16 min
We recently spoke to Lance Baldo, CEO of Beacon Therapeutics, during the Jefferies Healthcare Conference. Lees meer
Beacon's Vista ph3 trial for laru-zova, their AAV Gene Therapy for X-Linked Retinitis Pigmentosa, has completed enrolment with topline expected in mid-2026.
Listen in to hear about Lance's career, from roles with Roche in both Switzerland & New Zealand to a return to the US with Genentech's ophthalmology division, and how he's drawn on those experiences in his role as CEO of Beacon.
We also cover Lance's experience as a first-time CEO, and his advice for other executives making that transition, on topics as broad as fundraising, regulatory discussions, and team building.
And of course, we cover the story behind Beacon & their mission to deliver a step-change for XLRP patients globally.